STRATAGENE CORP 4
4 · STRATAGENE CORP · Filed Jun 8, 2007
Insider Transaction Report
Form 4
STRATAGENE CORPSTGN
Sorge Joseph A MD
DirectorPresident, CEO Chairman of Bd10% Owner
Transactions
- Disposition from Tender
Common Stock
2007-06-06$10.94/sh−9,784,089$107,037,934→ 0 total - Disposition from Tender
Employee Stock Option (Right to Buy)
2007-06-06$9.00/sh−17,500$157,500→ 0 totalExercise: $9.00Exp: 2007-12-31→ Common Stock (17,500 underlying) - Disposition from Tender
Common Stock
2007-06-06$10.94/sh−226,560$2,478,566→ 0 total(indirect: By Trust) - Disposition from Tender
Common Stock
2007-06-06$10.94/sh−319,753$3,498,098→ 0 total(indirect: By Trust) - Disposition from Tender
Common Stock
2007-06-06$10.94/sh−1,344,000$14,703,360→ 0 total(indirect: By Trust) - Disposition from Tender
Employee Stock Option (Right to Buy)
2007-06-06$9.34/sh−738,960$6,901,886→ 0 totalExercise: $9.34Exp: 2014-06-03→ Common Stock (738,960 underlying) - Disposition from Tender
Common Stock
2007-06-06$10.94/sh−86,125$942,208→ 0 total(indirect: By BioSense Partners, LP)
Footnotes (2)
- [F1]Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement") dated April 5, 2007, among the issuer, Agilent Technologies, Inc. and Jackson Acquisition Corp., in exchange for the right to receive a cash payment per share of $10.94.
- [F2]Pursuant to the Merger Agreement, these options, whether vested or unvested, were converted into the right to receive a cash payment per share underlying the options equal to the difference between the exercise price and $10.94.